Brief: Catabasis Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results And Provides A Corporate Update
March 11 (Reuters) - Catabasis Pharmaceuticals Inc CATB.O :
* CATABASIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2020 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.45
Source text for Eikon: ID:nBw7P2pWja
Further company coverage: CATB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astria Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:59 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM